D06.9
Carcinoma in situ of cervix, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Carcinoma in situ of the cervix is a condition where abnormal cells are found on the surface of the cervix but have not invaded deeper tissues or spread to other parts of the body. This early stage of cervical cancer is highly treatable when detected promptly. The term 'in situ' signifies that the cancerous cells are confined to the original site and have not yet developed invasive properties. The ICD-10 code D06.9 is used to classify cases where this condition is diagnosed but the specific type or location details are unspecified, making it essential for healthcare providers to conduct thorough evaluations for appropriate care.
Causes & Symptoms
Clinical Causes: Persistent infection with high-risk human papillomavirus (HPV) types Multiple sexual partners or early sexual activity Weakened immune system Smoking and exposure to tobacco smoke Long-term use of oral contraceptives Having a history of abnormal Pap smear results Other factors that compromise cervical health
Key Symptoms: Often no noticeable symptoms in early stages Abnormal vaginal bleeding, especially after intercourse, between periods, or after menopause Unusual vaginal discharge that may be watery, bloody, or foul-smelling Pelvic discomfort or pain in some cases Post-coital bleeding or spotting
Diagnostic & Treatment
Diagnosis Path: Diagnosis of carcinoma in situ of the cervix typically begins with screening procedures such as Pap smears, which can detect abnormal cells early. If abnormal cells are suspected, healthcare providers may recommend further tests, including:
Treatment Protocols: Treatment strategies focus on removing or destroying abnormal cells to prevent progression to invasive cancer. Options include:
Clinical Advice & FAQs
Billing Guidance
Is D06.9 a billable ICD-10 code?
Yes, D06.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D06.9?
Clinical documentation must specify the nature of Carcinoma in situ of cervix, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference